Cellebrite DI Ltd. (NASDAQ:CLBT) Position Increased by Hsbc Holdings PLC

Hsbc Holdings PLC raised its position in Cellebrite DI Ltd. (NASDAQ:CLBT) by 44.7% during the second quarter, HoldingsChannel.com reports. The firm owned 238,002 shares of the company’s stock after buying an additional 73,533 shares during the quarter. Hsbc Holdings PLC’s holdings in Cellebrite DI were worth $2,866,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Pembroke Management LTD increased its holdings in Cellebrite DI by 104.9% in the second quarter. Pembroke Management LTD now owns 1,535,726 shares of the company’s stock worth $18,352,000 after buying an additional 786,310 shares during the last quarter. Scalar Gauge Management LLC acquired a new position in shares of Cellebrite DI during the 4th quarter worth $5,914,000. Acadian Asset Management LLC raised its holdings in shares of Cellebrite DI by 26.8% during the 1st quarter. Acadian Asset Management LLC now owns 2,896,497 shares of the company’s stock valued at $32,062,000 after purchasing an additional 612,787 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its holdings in Cellebrite DI by 7.8% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 7,086,158 shares of the company’s stock worth $56,446,000 after purchasing an additional 514,858 shares in the last quarter. Finally, Ashford Capital Management Inc. boosted its holdings in Cellebrite DI by 23.5% in the first quarter. Ashford Capital Management Inc. now owns 1,841,240 shares of the company’s stock worth $20,401,000 after purchasing an additional 350,140 shares in the last quarter. 45.88% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. TD Cowen boosted their price target on Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a research report on Monday. Bank of America upped their target price on Cellebrite DI from $13.00 to $17.00 and gave the stock a “buy” rating in a research report on Friday, August 16th. JPMorgan Chase & Co. lifted their price target on shares of Cellebrite DI from $14.00 to $15.00 and gave the company an “overweight” rating in a research report on Wednesday, August 14th. Needham & Company LLC upped their price objective on shares of Cellebrite DI from $14.00 to $17.00 and gave the stock a “buy” rating in a report on Friday, August 16th. Finally, Lake Street Capital lifted their target price on shares of Cellebrite DI from $13.50 to $17.00 and gave the stock a “buy” rating in a report on Friday, August 16th. Eight equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $18.57.

Cellebrite DI Price Performance

NASDAQ CLBT opened at $16.63 on Thursday. The company’s fifty day moving average is $15.43 and its two-hundred day moving average is $12.79. Cellebrite DI Ltd. has a 52-week low of $6.36 and a 52-week high of $17.82. The firm has a market capitalization of $3.42 billion, a price-to-earnings ratio of -28.66, a P/E/G ratio of 2.38 and a beta of 1.52.

Cellebrite DI (NASDAQ:CLBT) last released its earnings results on Thursday, August 15th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. The business had revenue of $95.70 million for the quarter, compared to the consensus estimate of $91.94 million. Cellebrite DI had a positive return on equity of 5,902.06% and a negative net margin of 28.51%. The firm’s revenue for the quarter was up 24.8% compared to the same quarter last year. During the same period last year, the business earned $0.05 earnings per share. As a group, sell-side analysts expect that Cellebrite DI Ltd. will post 0.31 earnings per share for the current fiscal year.

Cellebrite DI Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.